Basso Capital Management, L.P. Biotech Acquisition CO Transaction History

Basso Capital Management, L.P.

$106 Million
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 11, 2022	SELL	$8.96 - $9.97 $1.07 Million - $1.19 Million	-119,539 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$9.75 - $9.91 $263 - $267	-27 Reduced 0.02%	119,539 $1.18 Million
Q4 2021 Feb 14, 2022	SELL	$9.73 - $9.91 $273,782 - $278,847	-28,138 Reduced 19.05%	119,566 $1.18 Million
Q3 2021 Nov 09, 2021	BUY	$9.64 - $9.75 $40,420 - $40,881	4,193 Added 2.92%	147,704 $1.44 Million
Q2 2021 Aug 13, 2021	BUY	$9.64 - $9.88 $642,612 - $658,610	66,661 Added 86.74%	143,511 $1.39 Million
Q1 2021 May 10, 2021	BUY	$9.56 - $9.73 $734,686 - $747,750	76,850 New	76,850 $747,000

Others Institutions Holding BIOT

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Biotech Acquisition Co

Ticker BIOT
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 23,000,000
Description
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

More about BIOT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Basso Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Basso Capital Management, L.P. with notifications on news.